By reviewing literature, we have discovered that the low GATA1 expression is associated with poor prognosis of clear renal cell carcinoma and recurrence of lymph node metastasis (Peters et al., 2015). Here, GATA1 is linked to metastatic malignant neoplasm in the lymph nodes.